Posted by Michael Wonder on 03 Apr 2026
NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with US
2 April 2026 - New partnership accelerates NHS patients' access to new medicines and will see UK benefit from greater life sciences industry investment.
Thousands of NHS patients will get improved access to life-changing treatments, after the government today agreed the full text of its landmark US-UK pharmaceutical partnership.
UK pharmaceutical exports to the US — worth at least £5 billion/year — will enter the US completely tariff free, for at least 3 years. This makes the UK the first country in the world to secure 0% tariffs on pharmaceutical exports to the US.
